(2026). Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs. PLOS Global Public Health.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Leveraging Current Capacity to Address the High Prevalence of Chlamydia Trachomatis, Neisseria Gonorrhoeae, and Trichomonas Vaginalis in South Africa: Modelling Potential Costs and Benefits of Near Point-of-care GeneXpert Testing for STIs."
PLOS Global Public Health 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Leveraging Current Capacity to Address the High Prevalence of Chlamydia Trachomatis, Neisseria Gonorrhoeae, and Trichomonas Vaginalis in South Africa: Modelling Potential Costs and Benefits of Near Point-of-care GeneXpert Testing for STIs."
PLOS Global Public Health, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.